Fasenra Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Each prefilled syringe contains 30 mg benralizumab in 1 mL.
Benralizumab is a humanised, afucosylated, monoclonal antibody selective for interleukin-5Rα. Benralizumab is of the IgG1/κ-class produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. Benralizumab has a molecular weight of approximately 150 kDa.
Excipients/Inactive Ingredients: L-histidine, L-histidine hydrochloride monohydrate, α,α-trehalose dihydrate, Polysorbate 20, Water for Injection.

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma